Sartorius Aktiengesellschaft (SUVPF)
USD 224.0
(0.0%)
USD 224.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 873.1 Million EUR | -40.75% |
| 2022 | 1.42 Billion EUR | 47.16% |
| 2021 | 926.6 Million EUR | 37.34% |
| 2020 | 704.06 Million EUR | 44.12% |
| 2019 | 488.53 Million EUR | 20.59% |
| 2018 | 398.58 Million EUR | 15.99% |
| 2017 | 349.29 Million EUR | 8.71% |
| 2016 | 321.32 Million EUR | 26.43% |
| 2015 | 241.19 Million EUR | 36.77% |
| 2014 | 185.82 Million EUR | 8.36% |
| 2013 | 171.49 Million EUR | 4.72% |
| 2012 | 163.76 Million EUR | 29.2% |
| 2011 | 123.88 Million EUR | 17.13% |
| 2010 | 104.28 Million EUR | 87.26% |
| 2009 | 54.31 Million EUR | -28.69% |
| 2008 | 81.04 Million EUR | 3.49% |
| 2007 | 83.29 Million EUR | 8.63% |
| 2006 | 68.36 Million EUR | 33.1% |
| 2005 | 57.42 Million EUR | 7.67% |
| 2004 | 50.3 Million EUR | 53.37% |
| 2003 | 32.79 Million EUR | 6.82% |
| 2002 | 30.7 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 247.8 Million EUR | -4.93% |
| 2024 Q3 | 181.2 Million EUR | -18.96% |
| 2024 Q1 | 239.5 Million EUR | 51.25% |
| 2023 Q4 | 155.5 Million EUR | -14.33% |
| 2023 FY | - EUR | -40.75% |
| 2023 Q2 | 285.2 Million EUR | 4.74% |
| 2023 Q1 | 272.3 Million EUR | -6.62% |
| 2023 Q3 | 181.5 Million EUR | -36.36% |
| 2022 Q4 | 291.6 Million EUR | -24.77% |
| 2022 FY | - EUR | 47.16% |
| 2022 Q1 | 434.1 Million EUR | 588.86% |
| 2022 Q2 | 390.6 Million EUR | -10.02% |
| 2022 Q3 | 387.6 Million EUR | -0.77% |
| 2021 Q1 | 268.8 Million EUR | 56.6% |
| 2021 FY | - EUR | 37.34% |
| 2021 Q2 | 290.3 Million EUR | 8.0% |
| 2021 Q3 | 304.5 Million EUR | 4.89% |
| 2021 Q4 | 63.01 Million EUR | -79.3% |
| 2020 Q2 | 144.1 Million EUR | 4.27% |
| 2020 Q4 | 171.64 Million EUR | -12.83% |
| 2020 Q1 | 138.2 Million EUR | 16.49% |
| 2020 FY | - EUR | 44.12% |
| 2020 Q3 | 196.9 Million EUR | 36.64% |
| 2019 Q1 | 111.8 Million EUR | 6.95% |
| 2019 Q3 | 119.5 Million EUR | -0.58% |
| 2019 Q4 | 118.63 Million EUR | -0.73% |
| 2019 FY | - EUR | 20.59% |
| 2019 Q2 | 120.2 Million EUR | 7.51% |
| 2018 Q4 | 104.53 Million EUR | 1.78% |
| 2018 Q1 | 85 Million EUR | 27.82% |
| 2018 FY | - EUR | 15.99% |
| 2018 Q3 | 102.7 Million EUR | 9.14% |
| 2018 Q2 | 94.1 Million EUR | 10.71% |
| 2017 Q3 | 80.3 Million EUR | -5.42% |
| 2017 FY | - EUR | 8.71% |
| 2017 Q2 | 84.9 Million EUR | 6.52% |
| 2017 Q4 | 66.5 Million EUR | -17.18% |
| 2017 Q1 | 79.7 Million EUR | 38.02% |
| 2016 Q2 | 81 Million EUR | 14.57% |
| 2016 Q4 | 57.74 Million EUR | -27.82% |
| 2016 Q1 | 70.7 Million EUR | 51.51% |
| 2016 Q3 | 80 Million EUR | -1.23% |
| 2016 FY | - EUR | 26.43% |
| 2015 Q4 | 46.66 Million EUR | -35.01% |
| 2015 Q1 | 60.3 Million EUR | 99.98% |
| 2015 Q2 | 62.1 Million EUR | 2.99% |
| 2015 Q3 | 71.8 Million EUR | 15.62% |
| 2015 FY | - EUR | 36.77% |
| 2014 Q3 | 48.6 Million EUR | 4.07% |
| 2014 FY | - EUR | 8.36% |
| 2014 Q4 | 30.15 Million EUR | -37.96% |
| 2014 Q2 | 46.7 Million EUR | 19.74% |
| 2014 Q1 | 39 Million EUR | 3.32% |
| 2013 Q2 | 43.9 Million EUR | 11.42% |
| 2013 Q4 | 37.74 Million EUR | -5.4% |
| 2013 FY | - EUR | 4.72% |
| 2013 Q1 | 39.4 Million EUR | 2.64% |
| 2013 Q3 | 39.9 Million EUR | -9.11% |
| 2012 Q3 | 40.9 Million EUR | 12.36% |
| 2012 Q1 | 36.2 Million EUR | 7.88% |
| 2012 Q2 | 36.4 Million EUR | 0.55% |
| 2012 FY | - EUR | 29.2% |
| 2012 Q4 | 38.38 Million EUR | -6.15% |
| 2011 Q2 | 29.1 Million EUR | -1.02% |
| 2011 Q1 | 29.4 Million EUR | 5.59% |
| 2011 Q3 | 34.6 Million EUR | 18.9% |
| 2011 Q4 | 33.55 Million EUR | -3.02% |
| 2011 FY | - EUR | 17.13% |
| 2010 Q1 | 21.6 Million EUR | 14.95% |
| 2010 Q4 | 27.84 Million EUR | 2.75% |
| 2010 FY | - EUR | 87.26% |
| 2010 Q2 | 25.2 Million EUR | 16.67% |
| 2010 Q3 | 27.1 Million EUR | 7.54% |
| 2009 Q2 | 6.1 Million EUR | -62.11% |
| 2009 Q1 | 16.1 Million EUR | 0.0% |
| 2009 Q4 | 18.79 Million EUR | -2.64% |
| 2009 Q3 | 19.3 Million EUR | 216.39% |
| 2009 FY | - EUR | -28.69% |
| 2008 FY | - EUR | 3.49% |
| 2007 FY | - EUR | 8.63% |
| 2006 FY | - EUR | 33.1% |
| 2005 FY | - EUR | 7.67% |
| 2004 FY | - EUR | 53.37% |
| 2003 FY | - EUR | 6.82% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 90674.861% |
| Ansell Limited | 209.86 Million USD | -316.037% |
| Ansell Limited | 206.3 Million USD | -323.219% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -1938.058% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 53830.851% |
| Psykey, Inc. | -1.29 Million USD | 67505.026% |
| ConvaTec Group Plc | 455.5 Million USD | -91.679% |
| ConvaTec Group Plc | 455.5 Million USD | -91.679% |
| Encision Inc. | -544.19 Thousand USD | 160538.813% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 615782.956% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 794332.694% |
| Innovative MedTech Inc. | -7.67 Million USD | 11477.649% |
| LifePoint, Inc. | -14.2 Million USD | 6247.666% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 14211.847% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 268746.154% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 405751.523% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 215263.732% |
| SmileDirectClub, Inc. | -186.13 Million USD | 569.058% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -94.965% |
| SheerVision, Inc. | -110.53 Thousand USD | 790014.142% |
| United Health Products, Inc. | -2.5 Million USD | 34993.099% |
| Vasamed, Inc. | -4.57 Million USD | 19186.481% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 38720.166% |
| Yubo International Biotech Limited | -1.17 Million USD | 74236.909% |